EGFR and head and neck squamous cell carcinoma: Although existing data on MVs in HNSCC are promising, a more detailed analysis of their molecular content may reveal novel biomarkers and help to elucidate mechanisms of tumor progression and therapeutic resistance, particularly during anti‐EGFR therapy.